GLP1R and type 2 diabetes mellitus: GLP-1 RAs, such as semaglutide, have shown consistent benefits beyond glycemic control, including reductions in body weight, improvements in metabolic parameters, and favorable changes in body composition in individuals with T2D and obesity [4,5].